T Cell–Depleted Unrelated Donor Stem Cell Transplantation Provides Favorable Disease-Free Survival for Adults with Hematologic Malignancies
Open Access
- 12 January 2011
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (9) , 1335-1342
- https://doi.org/10.1016/j.bbmt.2011.01.005
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute, National Institutes of Health, the Aubrey Fund, the Tow Foundation, and the Laura Rosenberg Foundation (P01 CA23766)
This publication has 53 references indexed in Scilit:
- Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic MalignanciesTransplantation and Cellular Therapy, 2010
- Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionHaematologica, 2009
- T cell–depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulinBlood, 2007
- Absolute Lymphocyte Count on Day 30 Is a Surrogate for Robust Hematopoietic Recovery and Strongly Predicts Outcome after T Cell-Depleted Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen–Identical Siblings Versus Human Leukocyte Antigen–Allelic–Matched Unrelated Donors (10/10) in Patients With Standard-Risk Hematologic Malignancy: A Prospective Study From the French Society of Bone Marrow Transplantation and Cell TherapyJournal of Clinical Oncology, 2006
- Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypesBlood, 2005
- High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationLeukemia, 2005
- Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood, 2002
- Transplantation tolerance induced by “mega dose” CD34+ cell transplantsExperimental Hematology, 2000
- IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADEBritish Journal of Haematology, 1997